Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

The companies will combine their complementary expertise in synthetic oligosaccharides, conjugation process development and GMP vaccine manufacturing to support partners developing next-generation con ...

The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or ...

Leishmaniasis is present in approximately 200 countries worldwide, being a major public health problem primarily in the Americas, East Africa, North Africa, ...

Cancer immunotherapy approaches that induce or amplify endogenous antitumour T cell responses require the presentation of tumour-specific antigens by human leukocyte antigen (HLA) molecules on the ...

For the first time, an AI-designed vaccine has passed a human clinical trial.

Vaccines are the most efficacious means of minimizing the impact of infectious diseases on the human population. The challenges and importance of making vaccines that will meet FDA approval have never ...